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Since large molecules are considered the key driver for growth of the pharmaceutical 
industry, the focus is shifting from small molecules to biopharmaceuticals. The list of 
approved biopharmaceutical drug products from the Food and Drug Administration (FDA) 
and European Medicines Agency (EMA) consists of approximately 50% freeze-dried 
products (Constantino and Pikal, 2004). Therefore, freeze-drying is the preferred way to 
stabilise biopharmaceutical drug products which are unstable in aqueous solution. However, 
freeze-drying requires a lot of energy and has a long processing time, making it a costly 
process (Burns, 2009; Gieseler, 2012). The largest fraction of freeze-dried biopharmaceutical 
products are therapeutic protein formulations and vaccines (Pikal, 2002). 
Conventional pharmaceutical freeze-drying (lyophilisation) is a batch process that consists of 
three consecutive steps: freezing, primary drying (ice sublimation) and secondary drying 
(desorption of unfrozen water). During the primary drying step the temperature at the 
sublimation front is critical, and should not exceed a critical value (dependent on the freeze-
dried product) to prevent cake collapse. In this project, the focus is on the modelling of the 
primary drying step. The purpose of the model is to use it to support future optimisation of the 
process parameters during operation of the freeze-dryer in a dynamic way. During primary 
drying only two process parameters are adaptable, i.e. the shelf temperature and the chamber 
pressure. In conventional pharmaceutical manufacturing, both process parameters are fixed, 
resulting in a conservative cycle. However, by dynamically updating both variables (i.e. 
resulting in a time variant Design Space), a substantial decrease in processing time can be 
obtained. 
The modelling approach can benefit from incorporating model parameter uncertainty to 
prevent that the critical temperature at the sublimation front is exceeded. Once the time 
variant Design Space is created for a certain set-up (i.e. a combination of a specific product 
and a piece of freeze-drying equipment), the values for both process variables can be fed to 
the equipment and a significant decrease in processing time can be obtained. As a result, the 
cost of processing will also be decreasing. Moreover, end product quality is guaranteed. 
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